These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 17697004

  • 1. Evidence for low risk of Clostridium difficile infection associated with tigecycline.
    Wilcox MH.
    Clin Microbiol Infect; 2007 Oct; 13(10):949-52. PubMed ID: 17697004
    [Abstract] [Full Text] [Related]

  • 2. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.
    Baines SD, Saxton K, Freeman J, Wilcox MH.
    J Antimicrob Chemother; 2006 Nov; 58(5):1062-5. PubMed ID: 17030519
    [Abstract] [Full Text] [Related]

  • 3. Activity of tigecycline against recent European clinical isolates of Clostridium difficile.
    Hawser SP.
    Int J Antimicrob Agents; 2010 Jan; 35(1):97-8. PubMed ID: 19892528
    [No Abstract] [Full Text] [Related]

  • 4. Tigecycline for the treatment of severe Clostridium difficile infection.
    Larson KC, Belliveau PP, Spooner LM.
    Ann Pharmacother; 2011 Jul; 45(7-8):1005-10. PubMed ID: 21730279
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
    Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL.
    J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tigecycline in-vitro susceptibility and antibiotics' fitness for gram-negative pathogens.
    Arya SC, Agarwal N.
    Saudi Med J; 2008 Nov; 29(11):1558-60. PubMed ID: 18998000
    [Abstract] [Full Text] [Related]

  • 15. Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature.
    Di Bella S, Nisii C, Petrosillo N.
    Int J Antimicrob Agents; 2015 Jul; 46(1):8-12. PubMed ID: 25982915
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.